Conning Inc’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,615
| Closed | -$817K | – | 449 |
|
|
2020
Q1 | $817K | Sell |
4,615
-57
| -1% | -$10.7K | 0.03% | 196 |
|
|
2019
Q4 | $893K | Buy |
4,672
+160
| +4% | +$28.9K | 0.03% | 218 |
|
|
2019
Q3 | $759K | Sell |
4,512
-318
| -7% | -$51.8K | 0.03% | 251 |
|
|
2019
Q2 | $809K | Sell |
4,830
-730
| -13% | -$101K | 0.03% | 241 |
|
|
2019
Q1 | $814K | Sell |
5,560
-376
| -6% | -$54.5K | 0.03% | 272 |
|
|
2018
Q4 | $793K | Sell |
5,936
-1,143
| -16% | -$187K | 0.03% | 264 |
|
|
2018
Q3 | $1.35M | Sell |
7,079
-610
| -8% | -$112K | 0.04% | 229 |
|
|
2018
Q2 | $1.28M | Sell |
7,689
-200
| -3% | -$32.1K | 0.04% | 252 |
|
|
2018
Q1 | $1.33M | Buy |
7,889
+130
| +2% | +$21.8K | 0.04% | 235 |
|
|
2017
Q4 | $1.27M | Sell |
7,759
-854
| -10% | -$153K | 0.04% | 251 |
|
|
2017
Q3 | $1.76M | Sell |
8,613
-80
| -0.9% | -$18.6K | 0.06% | 208 |
|
|
2017
Q2 | $2.11M | Sell |
8,693
-371
| -4% | -$87.2K | 0.08% | 181 |
|
|
2017
Q1 | $2.17M | Sell |
9,064
-985
| -10% | -$229K | 0.08% | 172 |
|
|
2016
Q4 | $2.11M | Sell |
10,049
-438
| -4% | -$90.7K | 0.08% | 173 |
|
|
2016
Q3 | $2.42M | Buy |
10,487
+100
| +1% | +$24.4K | 0.1% | 159 |
|
|
2016
Q2 | $2.4M | Buy |
10,387
+10
| +0.1% | +$2.31K | 0.1% | 160 |
|
|
2016
Q1 | $2.78M | Buy |
10,377
+220
| +2% | +$63K | 0.12% | 140 |
|
|
2015
Q4 | $3.17M | Sell |
10,157
-330
| -3% | -$98.2K | 0.14% | 131 |
|
|
2015
Q3 | $2.85M | Sell |
10,487
-1,000
| -9% | -$307K | 0.13% | 134 |
|
|
2015
Q2 | $3.49M | Buy |
11,487
+18
| +0.2% | +$5.37K | 0.14% | 124 |
|
|
2015
Q1 | $3.41M | Buy |
11,469
+4,069
| +55% | +$1.16M | 0.15% | 108 |
|
|
2014
Q4 | $1.91M | Sell |
7,400
-149
| -2% | -$37.2K | 0.09% | 163 |
|
|
2014
Q3 | $1.82M | Buy |
7,549
+2,544
| +51% | +$569K | 0.1% | 161 |
|
|
2014
Q2 | $1.12M | Hold |
5,005
| – | – | 0.06% | 224 |
|
|
2014
Q1 | $1.03M | Buy |
5,005
+720
| +17% | +$143K | 0.06% | 226 |
|
|
2013
Q4 | $720K | Buy |
4,285
+852
| +25% | +$133K | 0.04% | 264 |
|
|
2013
Q3 | $494K | Buy |
3,433
+228
| +7% | +$30.4K | 0.04% | 291 |
|
|
2013
Q2 | $405K | Buy |
+3,205
| New | +$363K | 0.03% | 305 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Conning Inc's AGN Position: Q2 2020 in Review
Conning Inc sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,615 shares — an estimated $817K sold.
Conning Inc first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $3.49M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Conning Inc reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Conning Inc sold 4,615 Allergan plc shares in Q2 2020, an estimated $817K.
- Conning Inc first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Conning Inc's Allergan plc position peaked at $3.49M in Q2 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Conning Inc's 13F filing for Q2 2020, filed 7 Aug 2020.